PLX News and Press, Protalix BioTherapeutics Inc.

2026-03-18 10:13:09 ET More on Protalix BioTherapeutics Protalix BioTherapeutics, Inc. (PLX) Q4 2025 Earnings Call Transcript A March Decision That Could Change Protalix BioTherapeutics Outlook Protalix BioTherapeutics misses top-line and bottom-line estimates; gives...

2026-03-18 10:12:25 ET Protalix BioTherapeutics, Inc. (PLX) Q4 2025 Earnings Call March 18, 2026 8:00 AM EDT... Read the full article on Seeking Alpha For further details see: Protalix BioTherapeutics, Inc. (PLX) Q4 2025 Earnings Call Transcript

A look at the top 10 most actives in the United States Li Bang International Corporation Inc. (LBGJ) rose 214.3% to $0.0965 on volume of 583,795,492 shares YY Group Holding Limited (YYGH) rose 34.5% to $0.0511 on volume of 524,984,097 shares VolitionRX Limited (VNRX) rose 33.3% to $0.2532 o...

2026-03-18 06:54:37 ET More on Protalix BioTherapeutics A March Decision That Could Change Protalix BioTherapeutics Outlook Protalix says EU panel recommended a new dosing regimen for Fabry disease therapy Seeking Alpha’s Quant Rating on Protalix BioTherapeuti...

Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results PR Newswire Company to host conference call and webcast today at 8:00 a.m. EDT The European Commission (EC) approved the 2mg/kg every-4-weeks (E4W) dosing regimen for Elfabrio ® in adults livi...

2026-03-17 15:24:48 ET More on Protalix BioTherapeutics A March Decision That Could Change Protalix BioTherapeutics Outlook Protalix says EU panel recommended a new dosing regimen for Fabry disease therapy Seeking Alpha’s Quant Rating on Protalix BioTherapeuti...

2026-03-15 08:07:28 ET Wall Street has entered a quieter phase of the earnings calendar, but the macro environment is shouting. While the earnings calendar has thinned out, the upcoming week still brings key reports from a diverse set of companies across various sectors: semiconductors, clo...

Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026 PR Newswire Company to host conference call and webcast at 8:00 a.m. EDT CARMIEL, Israel , March 11, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE Ame...

This press release is intended for US audiences for transparency relative to global news for the Fabry community. This dosing regimen for Elfabrio is not approved in the US. In the US, the FDA-approved dosing regimen remains 1mg/kg every 2 weeks. Please see Important Safety Information below and ...

2026-02-01 21:27:08 ET Thesis As you know, Protalix Bio Therapeutics ( PLX ) has just announced some news that should serve as a very positive regulatory and clinical milestone for their Fabry disease treatment in Europe. You see, the EMA’s Committee for Medicinal Pro...